Original Research

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma

Dunlap KM, Bartee MY, Bartee E

Oncolytic Virotherapy 2015, 4:1-11

Published Date: 13 January 2015